BioLife Solutions is poised to benefit from the booming cell and gene therapy sector. Read more to see my investment strategy ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: All sites on hold. We do appreciate your patience in holding and ask ...

More than 60% of operating profit is derived from resilient categories with low private label penetration and strong brand loyalty, where Nestle exhibits evident pricing power.

On the FTSE 350, Watches of Switzerland is down 15%, while Vietnam focused investment trusts VinaCapital Vietnam Opportunity ...

Higher EPS can lead to higher share prices, meaning these names could substantially support their stock using buybacks. Below are the details of three stocks that now have notable buyback capacity.

The Visible Alpha estimates were for adjusted EPS of $11.47 and revenue down about 0.7%. PVH also explained that it planned to enter into $500 million worth of accelerated share repurchase ...

B) Total number and yen amount of own shares repurchased from May 27, 2024 through March 31, 2025, pursuant to the Board of Directors resolution above: Total number of own shares repurchased ...

The repurchase program may be suspended or discontinued at any time. The company had approximately 54.3 million shares of common stock outstanding as of December 31, 2024. About Emergent BioSolutions ...

It also announced plans to enter into accelerated share repurchase agreements with ... increase slightly compared to 2024. Adjusted earnings per share is projected to be in a range of $12.40 ...

Emergent BioSolutions (NYSE:EBS – Get Free Report) declared that its board has approved a share repurchase plan on Monday, March 31st, RTT News reports. The company plans to buyback $50.00 million in ...

NEW YORK - Nexxen International Ltd. (NASDAQ: NEXN), a global advertising technology company currently valued at $530 million, has announced the repurchase ... an earnings per share (EPS) of ...